Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes. The cause of ...
The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...
In bladder cancer clinical trials in Europe, the recombinant BCG vaccine has demonstrated potent immunogenicity with CD8+ and CD4+ T cell stimulation and improved safety compared to earlier BCG ...
Prof. Ruth Nduati, a Paediatrician and Researcher, emphasises the critical role of BCG vaccine in protecting newborns. BCG, she explains acts as an antigen, teaching the body’s immune system to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results